Related Experiment Video
Updated: Apr 6, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae
Emina Karcic1, Mufida Aljicevic2, Sabaheta Bektas3
1Department of Pediatrics, Cantonal hospital, Zenica, Bosnia and Herzegovina.
Introduction:
Pneumococcal infections are a major cause of morbidity and mortality worldwide, whose treatment is threatened with an increase in the number of strains resistant to antibiotic therapy.
Goal:
The main goal of this research was to investigate the presence of antimicrobial susceptibility/resistance of S. pneumoniae.
Material And Methods:
Taken are swabs of the nose and nasopharynx, eye and ear. In vitro tests that were made in order to study the antimicrobial resistance of pneumococci are: disk diffusion method and E-test.
Results:
The resistance to inhibitors of cell wall synthesis was recorded at 39.17%, protein synthesis inhibitors 19.67%, folate antagonists 47.78% and quinolone in 1.11%. S. pneumoniae has shown drug resistance to erythromycin in 45%, clindamycin in 45%, chloramphenicol-0.56%, rifampicin-6.11%, tetracycline-4.67%, penicillin-G in 4.44%, oxacillin in 73.89%, ciprofloxacin in 1.11% and trimethoprim-sulfamethoxazole in 5.34% of cases.
Conclusion:
The highest resistance pneumococcus showed to erythromycin, clindamycin and trimethoprim-sulfamethoxazole and these should be avoided in the treatment. The least resistance pneumococcus showed to tetracycline, rifampicin, chloramphenicol, penicillin-G and ciprofloxacin.
Insights
Pneumococcal infections are a growing threat due to antibiotic resistance. This study found high resistance to erythromycin, clindamycin, and trimethoprim-sulfamethoxazole in Streptococcus pneumoniae, indicating these should be avoided in treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Pneumococcal infections pose a significant global health burden.
- Increasing antibiotic resistance in Streptococcus pneumoniae strains complicates treatment.
- Antimicrobial resistance threatens the efficacy of current therapeutic strategies.
Purpose of the Study:
- To investigate the antimicrobial susceptibility and resistance patterns of Streptococcus pneumoniae (S. pneumoniae).
- To identify prevalent resistance mechanisms in clinical isolates.
- To inform empirical treatment guidelines for pneumococcal infections.
Main Methods:
- Collection of clinical samples including nasal, nasopharyngeal, eye, and ear swabs.
- In vitro antimicrobial susceptibility testing using disk diffusion and E-test methods.
- Evaluation of resistance against various antibiotic classes, including cell wall synthesis inhibitors, protein synthesis inhibitors, folate antagonists, and quinolones.
Main Results:
- High resistance rates were observed for folate antagonists (47.78%) and cell wall synthesis inhibitors (39.17%).
- Specific drug resistance included erythromycin (45%), clindamycin (45%), and oxacillin (73.89%).
- Low resistance was noted for tetracycline (4.67%), penicillin-G (4.44%), and ciprofloxacin (1.11%).
Conclusions:
- Streptococcus pneumoniae exhibits significant resistance to erythromycin, clindamycin, and trimethoprim-sulfamethoxazole.
- These antibiotics should be used with caution or avoided in treating resistant pneumococcal infections.
- Tetracycline, rifampicin, chloramphenicol, penicillin-G, and ciprofloxacin demonstrated lower resistance rates.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Pneumonia III: Complications and Assessment

